Laurus Labs

LAURUSLABS · NSE · INR

1 972,30 ₹Variation par rapport à la clôture précédente: −0,59 %Variation absolue: −11,70 ₹

Clôture · 5 octobre 2026

Profil de la société

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Drug Manufacturers - Specialty & Generic
Pays
Inde
Siège
Jubilee Hills, 500033, Hyderabad
Salariés
7 059
Cotation
LAURUSLABS · NSE
Devise
INR